You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-783-ESGO Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma

Article metrics

Article menu

Download PDFPDF

Endometrial cancer
2022-RA-783-ESGO Clinical relevance of circulating ESR1 mutations during endocrine therapy for advanced hormone-dependent endometrial carcinoma
Free

 

Online download statistics by month:

Online download statistics by month: October 2022 to April 2024

AbstractFullPdf
Oct 20223805
Nov 20223002
Dec 202240010
Jan 20233403
Feb 20232802
Mar 20233400
Apr 20232000
May 20231802
Jun 20231802
Jul 20232606
Aug 20232204
Sep 20231602
Oct 2023801
Nov 20232306
Dec 20231902
Jan 2024601
Feb 2024600
Mar 20241501
Apr 20241002
Total411051